Form 4: EPAM CFO Jason D. Peterson Reports Stock Option Exercise and Sale

Sentiment:

SEC Form 4 Filing


EPAM Systems' CFO, Jason D. Peterson, exercised stock options and sold 2,000 shares of common stock on March 7, 2024.

Summary

  • On March 7, 2024, Jason D. Peterson, the Chief Financial Officer of EPAM Systems, Inc., exercised stock options to acquire 2,000 shares of EPAM common stock at a price of $169.13 per share.
  • Simultaneously, Peterson sold 2,000 shares of EPAM common stock at a price of $315 per share.
  • Following these transactions, Peterson directly owns 23,650 shares of EPAM common stock.
  • Peterson also holds options to purchase 1,088 shares of EPAM common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

  • Executive compensation packages often include stock options to align management's interests with those of shareholders.
  • The vesting schedule of the options (25% annually over four years) is a standard practice.
  • Similar transactions are regularly reported by executives at comparable companies in the IT services sector, such as Accenture, Tata Consultancy Services, and Infosys.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders.
  • Shareholders may view insider transactions as a signal of management's confidence (or lack thereof) in the company, but single transactions are not necessarily indicative of a trend.

Key Dates

DateDescription
03/29/202025% of stock option grant vested
03/29/202125% of stock option grant vested
03/29/202225% of stock option grant vested
03/29/202325% of stock option grant vested
03/07/2024Earliest transaction date: stock option exercise and stock sale
03/11/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.